NewsRx

Search our medical news database

InterCure Ltd.

RESPeRATE Achieves National Distribution at Boots Pharmacy

Published in Medical Letter on the CDC and FDA, August 30th, 2009

InterCure Ltd.,(www.intercure.com) a medical device company publicly traded on the Tel-Aviv Stock Exchange (TASE: INCR), announced that RESPeRATE®, the world's first FDA-cleared, over-the-counter blood pressure treatment device, will be sold nationwide in the UK through Boots Pharmacy Stores (www.boots.com). Following a successful trial at 100 stores, Boots is expanding the distribution to 600 of their leading stores, beginning November 2009.

With the expansion of the Boots business, RESPeRATE will now be available nationally in the UK's two largest multiple pharmacy chains. InterCure entered the UK pharmacy market in 2008, achieving broad distribution at 1,400...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook